SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Schedule 1 - Marwyn Materials Limited

17 Aug 2010 07:36

RNS Number : 1769R
AIM
17 August 2010
Β 

ο»Ώ

Β 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Β 

MARWYN MATERIALS LIMITED (the "Company"). The Company will change its name to Breedon Aggregates Ltd (Jersey) at Completion.

Β 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

Β 

Elizabeth House, 9 Castle Street, St Helier, Jersey, JE4 2QP

Β 

COUNTRY OF INCORPORATION:

Β 

Jersey

Β 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

Β 

www.marwynmaterials.com

Β 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

Β 

The Company was admitted to AIM on 12 June 2008 with the strategy of acquiring controlling stakes in one or more quoted or unquoted profitable businesses in the UK and international building materials industry and to use these as a platform for further acquisitions. The Directors have reviewed a number of potential acquisition targets since the Company was admitted to AIM and believe that the acquisition of Breedon represents an exciting opportunity within this strategy. The Company does not currently undertake any trading activity.

Β 

Marwyn Materials Investments Limited, a subsidiary of the Company ("the Subsidiary"), had entered into conditional acquisition agreements to acquire the entire issued share capital of Breedon Holdings Limited ("Breedon"), a large independent UK aggregates producer.

Β 

In view of the size of Breedon, the Acquisition will, on Completion, constitute a reverse takeover under Rule 14 of the AIM Rules for Companies.

Β 

Breedon is a fully integrated aggregates producer with 29 quarries, 19 asphalt plants and 27 concrete plants in England and Scotland, and the Directors believe it will provide the Company with a robust platform for accelerated growth through consolidation of the UK heavyside building materials sector. The business is backed by a strong asset base with approximately 181 million tonnes of mineral reserves and resources, providing an estimated life of approximately 50 years at current output levels. The Directors also believe that the business is well invested with a substantial amount of new plant in good condition.

Β 

Main country of operation: Jersey and UK (via the reverse takeover of Breedon Holdings Limited).

Β 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

Β 

416,666,667 Ordinary shares of no par value (which have been placed at 12p each).

Β 

There are no restrictions on the transfer of securities.

Β 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

Β 

Capital to be raised on Admission: Β£50.0 million

Β 

Market capitalisation (anticipated): Β£66.3 million

Β 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

Β 

78.5 per cent.

Β 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

Β 

N/A

Β 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Β 

Peter William Gregory Tom CBE (Chairman)

Simon Neil Vivian (Chief Executive)

James Henry Merrick Corsellis (Non-executive Director)

David John Warr (Non-executive Director)

David Jeffreys Williams (Non-executive Director)

Β 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Β 

Before Admission:

Β 

Name of shareholder

Number of ordinary shares

% of issued share capital

Marwyn Value Investors L.P.

50,010,000

36.8

Cenkos Channel Islands Nominee Company Limited

17,850,000

13.1

Corporate Services (TD Waterhouse) Nominees Limited

15,693,020

11.5

Β 

Post admission:

Β 

Name of shareholder

Number of ordinary shares

% of issued share capital

Marwyn Value Investors L.P

148,982,667

26.9

Cenkos Channel Islands Nominee Company Limited

67,849,667

12.3

Invesco plc

165,000,000

29.8

Morgan Stanley Securities Limited

25,000,000

4.5

Scottish Widows Investment Partnership

41,665,000

7.5

Β 

The BHL Lenders (being Barclays Bank plc, Allied Irish Banks p.l.c., the Governor and Company of the Bank of Ireland and KBC Bank NV) and Stephen Smith together hold warrants over 55,266,667 shares in the Company.

Β 

Β 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

Β 

Peter Tom CBE (Chairman)

Simon Vivian (Chief Executive Officer)

Β 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

Β 

(i) 31 December;

Β 

(ii) Audited consolidated results of the Breedon Group are included for the period from incorporation on 15 December 2008 to 31 December 2009.

Β 

(iii) 30 September 2010 (unaudited interims of Marwyn Materials Limited and unaudited interims of Breedon Group); 30 June 2011 (consolidated financial statements of the Enlarged Group) and 30 September 2011

Β 

EXPECTED ADMISSION DATE:

Β 

2 September 2010

Β 

NAME AND ADDRESS OF NOMINATED ADVISER:

Β 

Cenkos Securities plc

6. 7. 8. Tokenhouse Yard

London EC2R 7AS

Β 

NAME AND ADDRESS OF BROKER:

Β 

Cenkos Securities plc

6. 7. 8. Tokenhouse Yard

London EC2R 7AS

Β 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

Β 

Copies of the admission document will be available from www.marwynmaterials.com. The admission document contains full details about the applicant and the admission of its securities.

Β 

DATE OF NOTIFICATION:

Β 

17 August 2010

Β 

NEW/ UPDATE:

NEW

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
PAAPRMFTMBJBMFM
Date   Source Headline
9th Jun 20267:00 amRNSAcquisition
13th May 20265:41 pmRNSDirector/PDMR Shareholding
12th May 20262:03 pmRNSHolding(s) in Company
30th Apr 20263:14 pmRNSTotal Voting Rights
29th Apr 20265:01 pmRNSResult of AGM
29th Apr 20267:00 amRNSAGM Trading Update
16th Apr 20264:40 pmRNSDirector/PDMR Shareholding
14th Apr 20265:10 pmRNSDirector/PDMR Shareholding
10th Apr 20269:55 amRNSHolding(s) in Company
9th Apr 20263:29 pmRNSDirector/PDMR Shareholding
9th Apr 20269:07 amRNSHolding(s) in Company
8th Apr 20263:41 pmRNSDirector/PDMR Shareholding
7th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 20269:48 amRNS-RBacking British Cement
31st Mar 20262:08 pmRNSTotal Voting Rights
24th Mar 20264:36 pmRNSHolding(s) in Company
23rd Mar 20262:05 pmRNSHolding(s) in Company
23rd Mar 20262:04 pmRNSHolding(s) in Company
23rd Mar 202612:01 pmRNS2025 Annual Report and Notice of AGM
19th Mar 20269:20 amRNSHolding(s) in Company
18th Mar 202610:41 amRNSHolding(s) in Company
16th Mar 202611:43 amRNSHolding(s) in Company
11th Mar 202611:39 amRNS-RBacking British Cement
11th Mar 20267:00 amRNSFinal Results
4th Mar 20267:00 amRNS-RLive presentation via Investor Meet Company
27th Feb 20269:33 amRNSTotal Voting Rights
11th Feb 20264:01 pmRNSIssue of Shares
30th Jan 202612:44 pmRNSBlock Listing Update
30th Jan 20267:00 amRNSNotice of Annual Results 2025
31st Dec 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Dec 20257:00 amRNSTotal Voting Rights
2nd Dec 20253:49 pmRNSDirector/PDMR Shareholding
28th Nov 20253:29 pmRNSDirector/PDMR Shareholding
28th Nov 20258:55 amRNSTotal Voting Rights
26th Nov 20255:20 pmRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTrading Update
12th Nov 20253:30 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSAppointment of Joint Corporate Broker
31st Oct 202510:43 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTotal Voting Rights
29th Aug 20254:17 pmRNSTotal Voting Rights
29th Aug 20253:51 pmRNSHolding(s) in Company
29th Aug 20253:46 pmRNSHolding(s) in Company
29th Aug 202512:18 pmRNSDirector/PDMR Shareholding
13th Aug 202511:13 amRNSDirector/PDMR Shareholding
31st Jul 20258:51 amRNSTotal Voting Rights
24th Jul 202510:03 amRNSDirector/PDMR Shareholding
24th Jul 202510:02 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSInterim Results 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.